Twelve Seas Investment Company II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-Q
May 29, 2024 18:15 ET
|
Twelve Seas Investment Company II
New York, NY, May 29, 2024 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company II (NASDAQ): TWLV) (the “Company”) today announced that it has received a notice (the “Notice”) from the Listing...
First Guaranty Bancshares, Inc Announces CEO Retirement
May 29, 2024 17:56 ET
|
First Guaranty Bank
HAMMOND, La., May 29, 2024 (GLOBE NEWSWIRE) -- First Guaranty Bancshares, Inc. announced today that Alton Lewis will retire from his role as President and Chief Executive Officer of First Guaranty...
UPDATE - Freshpet, Inc. to Participate in the Deutsche Bank Global Consumer Conference
May 29, 2024 17:30 ET
|
Freshpet, Inc.
SECAUCUS, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that members of the executive management team will participate in the...
Tarsus to Participate in Upcoming Investor Conferences
May 29, 2024 17:00 ET
|
Tarsus Pharmaceuticals, Inc
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...
Descartes Announces Fiscal 2025 First Quarter Financial Results
May 29, 2024 17:00 ET
|
The Descartes Systems Group Inc.
Record Revenues and Income from Operations WATERLOO, Ontario and ATLANTA, May 29, 2024 (GLOBE NEWSWIRE) -- The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results...
Lilium Announces Successful Arrangement of $114 Million Capital Raise With Participation From Strategic and Existing Investors
May 29, 2024 17:00 ET
|
Lilium GmbH
MUNICH, Germany, May 29, 2024 (GLOBE NEWSWIRE) -- Lilium N.V. (NASDAQ: LILM) (“Lilium”), developer of the first all-electric vertical take-off and landing (eVTOL) jet and global pioneer in regional...
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 29, 2024 16:45 ET
|
Reviva Pharmaceuticals
CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that...
Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference
May 29, 2024 16:30 ET
|
Jasper Therapeutics, Inc.
REDWOOD CITY, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy...
Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024
May 29, 2024 16:30 ET
|
Cellectis Inc.
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
May 29, 2024 16:30 ET
|
ORIC Pharmaceuticals
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address...